Long acting insulin: Lantus
insulin glargine [rDNA origin] injection
small amounts of insulin glargine are
slowly released, resulting in
a relatively constant concentration
time profile over 24 hours with no peak
this makes it a patient’s basal insulin
comes in subq injection or orally.
After subcutaneous injection of insulin glargine in healthy
subjects and in patients with diabetes, the insulin serum concentrations
indicated a slower, more prolonged absorption and a relatively constant
concentration/time profile over 24 hours
improve glycemic control in patients with
type 1 diabetes mellitus
Improve glycemic control in
patients with type 2 diabetes mellitus
episodes of hypoglycemia
or diabetic ketoacidosis.
drug interactions with
ACE inhibitors, Beta-blockers
Possible adverse reactions
allergic reactions to the diluent
site injection reactions or infection
lipodystrophy at the injection site
know what signs and symptoms
help keep blood sugar
within normal ranges
Therapeutic effects expected
Question 1) what is lantus used to treat?
Question2) True or False, patient should continue to drink alcohol?